Friedreich Ataxia in Classical Galactosaemia
Siobhán Neville1, Siobhan O'Sullivan2, Bronagh Sweeney2
1National Centre for Inherited Metabolic Disorders, Temple Street Children's University Hospital, Dublin, Ireland.
JIMD Reports
|July 30, 2015
Summary
Classical galactosaemia and Friedreich ataxia (FRDA) co-occur in Irish Traveller families. Genetic linkage and increased prevalence highlight the importance of diagnosing FRDA in galactosaemia patients with neurological symptoms.
Area of Science:
- Genetics
- Neurology
- Metabolic Disorders
Background:
- Movement disorders like ataxia are known complications of classical galactosaemia, even with dietary compliance.
- Classical galactosaemia and Friedreich ataxia (FRDA) are both autosomal recessive disorders.
- Both conditions are observed with higher frequency in the Irish Traveller population.
Purpose of the Study:
- To report the coexistence of classical galactosaemia and FRDA in nine children from Irish Traveller families.
- To investigate potential genetic linkage between these two disorders in this specific population subgroup.
- To emphasize the importance of considering FRDA in galactosaemia patients presenting with neurological or cardiac issues.
Main Methods:
- Genetic analysis of the GALT gene for galactosaemia diagnosis (homozygous Q188R mutation identified).
- Genetic analysis of the FXN gene for FRDA diagnosis (common pathogenic GAA expansion identified).
- Clinical assessment of neurological and cardiac status in affected children.
Main Results:
- Nine children from seven Irish Traveller families were identified with both classical galactosaemia and FRDA.
- Eight patients presented with progressive ataxia between ages 5-13.
- One patient presented with dilated cardiomyopathy and heart failure at age 7, with normal neurological examination at follow-up.
Conclusions:
- Classical galactosaemia and FRDA show apparent linkage disequilibrium in this Irish Traveller subgroup.
- Neurological symptoms in galactosaemia patients can mask or be confused with FRDA.
- Early consideration of FRDA is crucial for Irish Traveller children diagnosed with galactosaemia who develop ataxia or cardiomyopathy.
Related Concept Videos
Inborn Errors of Metabolism
1.0K
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.0K
Glucose Transporters
28.3K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
28.3K
Incomplete Dominance
32.6K
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
32.6K
Translation
22.5K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
22.5K
Translation
161.3K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
161.3K
Cystic Fibrosis: Pathogenesis
1.1K
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K


